BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Rajnish Rohatgi Takes Charge as Orchid Pharma’s Newly Appointed CEO June 20, 2024 He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives.
Fosun Pharma to Pare 5% Stake in Gland Pharma for $172 Mn June 20, 2024 Fosun Pharma Industrial Pte, a subsidiary of Shanghai Fosun Pharmaceutical, has planned to reduce its stake in Gland Pharma by 5%, equating to $172 million.
SKAN Research Trust & Quadram Institute Bioscience Collaborate to Advance Microbial Therapies June 19, 2024 Bengaluru-based SKAN Research Trust, led by entrepreneur Ashok Soota, has joined forces with the UK-based Quadram Institute Bioscience to leverage the TraDIS-Xpress platform in a novel research initiative.
Kemwell Biopharma & RevOpsis Partner to Expedite Biologic Development June 18, 2024 US-based RevOpsis Therapeutics, a next-generation biopharmaceutical startup, has entered a strategic manufacturing partnership with Bengaluru-based Kemwell Biopharma.
Health Minister JP Nadda Holds Review Meeting with DoP June 17, 2024 Minister Nadda reiterated that quality should be a key focus, ensuring all manufacturing plants meet world-class standards within the stipulated time frame.
India's Growing Dependence on Chinese Bulk Drug Imports Persists Despite Policy Efforts June 13, 2024 This growing dependency comes amid efforts by the Indian government and the pharmaceutical industry to diversify sources and reduce reliance on China.
Kotak Alt Invests INR 1,445 Cr in Matrix Pharma for Viatris’ API Business Acquisition June 12, 2024 Reportedly, with this acquisition, Matrix Pharma is set to become the second-largest Indian player in the API market.
Gland Pharma Appoints Srinivas Sadu as Executive Chairman & CEO June 11, 2024 Per the pharma company, under Sadu's leadership, it has consistently achieved remarkable growth in revenue and profits while expanding its presence across various geographic regions.
IP Alliance Calls for US-India Affordable Medicine Partnership Amidst Priority Watch List Controversy June 11, 2024 The USTR's 2024 Special 301 Report has once again placed India on the Priority Watch List, indicating concerns over intellectual property (IP) protection and enforcement.
AstraZeneca Completes Acquisition of Fusion Pharma for $2.4 Bn June 7, 2024 This acquisition complements AstraZeneca’s leading oncology portfolio with the addition of the Fusion pipeline of RCs, including their most advanced programme, FPI-2265.
Mankind Pharma in Race to Buy Bharat Serum & Vaccines Group for INR 13,000 Cr June 7, 2024 In the latest update, Dr Reddy’s Laboratories may also join the race, having sought extra time to submit a bid for the Advent International portfolio company.
DoP Data Reveals Pharma PLI Witnessed INR 28,328 Cr Investment till April 2024 June 5, 2024 The Production Linked Incentive (PLI) Scheme for Pharmaceuticals reported significant progress, with 261 manufacturing locations commissioned by the end of April 2024.
